Press "Enter" to skip to content

New patent expiration for Bristol Myers drug GLUCOPHAGE XR


Annual Drug Patent Expirations for GLUCOPHAGE+XR
Annual Drug Patent Expirations for GLUCOPHAGE+XR

Glucophage Xr is a drug marketed by Bristol Myers Squibb
and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has seventeen patent family members in twelve countries.

The generic ingredient in GLUCOPHAGE XR is metformin hydrochloride. One supplier is listed for this compound. Additional details are available on the metformin hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!